Indian co’s bag 40 per cent of ANDAs approved

Indian co's bag 40 per cent of ANDAs approved

According to a report by Centrum Broking, Indian pharma companies bagged around 40% of all Abbreviated New Drug Approvals (ANDA) approvals from the US Food and Drug Administration (FDA) between January and July 2013. ANDA approval is a pre-requisite for marketing generic products in the US. Among the Indian companies, Sun Pharma and Aurobindo Pharma emerged the winners with 21 and 20 ANDA approvals respectively.

Read the source article at The Economic Times